Will the various companies and laboratories involved in the development of a vaccine against covid-19 be able to produce one that is “safe and effective”? According to Anthony Fauci, an American specialist in infectious diseases, this information will be known in about a month.
“We will know that there is a safe and effective vaccine in late November, early December,” said the expert in an interview with the BBC. Still, only a few will be able to enjoy it. Its widespread use, according to Fauci, will not happen until the end of 2021. “It is very unlikely that we will be able to vaccinate a substantial part of the population – and thereby change the dynamics of the virus – before the second or third quarter of the year”.
Even with a vaccine, precautions such as wearing a mask and social detachment will have to be maintained, said Fauci, who heads the US National Institute of Allergy and Infectious Diseases, at a Zoom conference with students at Thomas Jefferson University (Philadelphia) in last week. And also on that occasion, a specific deadline was presented: according to the specialist, these are rules that we will have to keep until the end of 2021, beginning of 2022. As for the vaccine, it will only be, according to your forecast, 70% effective, hence the need to to maintain these public health care and measures, even if not in a “as tight” way as at the moment.
Still in an interview with the BBC, Anthony Fauci drew attention to the need for politicians and public figures to respect science, something that Donald Trump will not be doing, by insisting that he is immune to the virus and, therefore, may be so close to people. as it was before the pandemic.
Pfizer hopes to have vaccine ready “within weeks”
There is a lot of pressure on the pharmaceutical industry and, therefore, promises are being made about the appearance of a vaccine soon. Recently, Paul Reid, director of Pfizer, hinted that the vaccine being developed by the company will be ready “within weeks”.
Approval by US and European health officials is expected to arrive later this month, he also told the Irish Independent, noting that 100 million doses of the vaccine are available. In the course of clinical trials, two doses are being administered to 44,000 people aged 12 and over.
–
